Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASARNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene therapies to genome editing and synthetic biology. However, designing RNA molecules that reliably fold into a desired secondary structure remains a major challenge. Even for relatively short sequences, the number of possible nucleotide combinations grows exponentially, making it difficult to identify optimal candidates. As a result, conventional computational methods often require extensive candidate evaluations, creating a significant bottleneck when experimental validation is both time-consuming and costly.
🛡️
We’re checking your connection to prevent automated abuse